N-chlorotaurine, a natural antiseptic with outstanding tolerability

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 3, 2010, Pages 399-409

  Gottardi, Waldemar ^a   Nagl, Markus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Active chlorine compounds; Biocide; Chloramines; Disinfection; Monochloramine

Indexed keywords

ANTIINFECTIVE AGENT; N CHLOROTAURINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTICOAGULATION; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; AQUEOUS SOLUTION; ARTHRITIS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TOLERABILITY; EXTERNAL OTITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LEG ULCER; NONHUMAN; OXIDATION; PH; REVIEW; RHINITIS; SINUSITIS; TEMPERATURE SENSITIVITY; URINARY TRACT INFECTION; VIRAL CONJUNCTIVITIS; VIRULENCE;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIA; CLINICAL TRIALS AS TOPIC; FUNGI; HUMANS; PARASITES; TAURINE; VIRUSES;

EID: 77950318741     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp466     Document Type: Review

References (105)

1. Klebanoff SJ. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol 1968; 95: 2131-8.
2. McRipley RJ, Sbarra AJ. Role of the phagocyte in host-parasite interactions. XII. Hydrogen peroxide-myeloperoxidase bactericidal system in the phagocyte. J Bacteriol 1967; 94: 1425-30.
3. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
4. Grisham MB, Jefferson MM, Melton DF et al. Chlorination of endogenous amines by isolated neutrophils. J Biol Chem 1984; 259: 10404-13.
5. Koprowski M, Marcinkiewicz J. Taurine chloramine-its role in immunity and new perspectives for clinical use. Centr Eur J Immunol 2002; 27: 69-74.
6. Marcinkiewicz J. Neutrophil chloramines: missing links between innate and acquired immunity. Immunol Today 1997; 18: 577-80.
7. Thomas EL, Lehrer RI, Rest RF. Human neutrophil antimicrobial activity. Rev Infect Dis 1988; 10 Suppl 2: S450-6.
8. Test ST, Lampert MB, Ossanna PJ et al. Generation of nitrogen-chlorine oxidants by human phagocytes. J Clin Invest 1984; 74: 1341-9.
9. Weiss SJ, Klein R, Slivka A et al. Chlorination of taurine by human neutrophils. J Clin Investig 1982; 70: 598-607.
10. Gottardi W, Nagl M. Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch Pharm Pharm Med Chem 2002; 335: 411-21.
11. Dakin HD. On the use of certain antiseptic substances in the treatment of infected wounds. BMJ 1915; 1915: 318-20.
12. Dakin HD. The behaviour of hypochlorites on intravenous injection and their action on blood serum. BMJ 1916; 1916: 852-4.
13. Dakin HD, Cohen JB. Studies in antiseptics (II): on chloramine: its preparation, properties, and use. BMJ 1916; 1916: 160-2.
14. Tilley FW, Chapin RM. Germicidal efficiency of chlorine and the N-chloro derivatives of ammonia, methylamine and glycine against anthrax spores. J Bacteriol 1930; 19: 295-302.
15. Stelmaszynska T, Zgliczynski JM. Myeloperoxidase of human neutrophilic granulocytes as chlorinating enzyme. Eur J Biochem 1974; 45: 305-12.
16. Zgliczynski JM, Stelmaszynska T, Domanski J et al. Chloramines as intermediates of oxidation reaction of amino acids by myeloperoxidase. Biochim Biophys Acta 1971; 235: 419-24.
17. Yazdanbakhsh M, Eckmann CM, Roos D. Killing of schistosomula by taurine chloramine and taurine bromamine. Am J Trop Med Hyg 1987; 37: 106-10.
18. Thomas EL. Myeloperoxidase, hydrogen peroxide, chloride antimicrobial system: effect of exogenous amines on the antibacterial action against Escherichia coli. Infect Immun 1979; 25: 110-6.
19. Thomas EL. Myeloperoxidase, hydrogen peroxide, chloride antimicrobial system: nitrogen-chlorine derivatives of bacterial components in bactericidal action against Escherichia coli. Infect Immun 1979; 23: 522-31.
20. Wagner DK, Collins Lech C, Sohnle PG. Inhibition of neutrophil killing of Candida albicans pseudohyphae by substances which quench hypochlorous acid and chloramines. Infect Immun 1986; 51: 731-5.
21. Gottardi W, Hagleitner M, Nagl M. The influence of plasma on the disinfecting activity of the new antimicrobial agent N-chlorotaurine sodium. J Pharm Pharmacol 2001; 53: 689-97.
22. Nagl M, Gottardi W. In vitro experiments on the bactericidal action of N-chlorotaurine. Hyg Med 1992; 17: 431-9.
23. Nagl M, Gottardi W. Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds. Hyg Med 1996; 21: 597-605.
24. Nagl M, Hess M, Pfaller K et al. Bactericidal activity of micromolar N-chlorotaurine-evidence for its antimicrobial function in the human defence system. Antimicrob Agents Chemother 2000; 44: 2507-13.
25. Nagl M, Lass-Floerl C, Neher A et al. Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother 2001; 47: 871-4.
26. Nagl M, Gruber A, Fuchs A et al. Impact of N-chlorotaurine on viability and production of secreted aspartyl proteinases of Candida spp. Antimicrob Agents Chemother 2002; 46: 1996-9.
27. Dudani AK, Martyres A, Fliss H. Short communication: rapid preparation of preventive and therapeutic whole-killed retroviral vaccines using the microbicide taurine chloramine. AIDS Res Hum Retroviruses 2008; 24: 635-42.
28. Nagl M, Larcher C, Gottardi W. Activity of N-chlorotaurine against herpes simplex- and adenoviruses. Antiviral Res 1998; 38: 25-30.
29. Romanowski EG, Yates KA, Teuchner B et al. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model. Invest Ophth Vis Sci 2006; 47: 2021-6.
30. Fürnkranz U, Nagl M, Gottardi W et al. Cytotoxic activities of N-chlorotaurine (NCT) on Acanthamoeba spp. Antimicrob Agents Chemother 2008; 52: 470-6.
31. Cantin AM. Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport. J Clin Investig 1994; 93: 606-14.
32. Davies JM, Horwitz DA, Davies KJ. Inhibition of collagenase activity by N-chlorotaurine, a product of activated neutrophils. Arthritis Rheum 1994; 37: 424-7.
33. Schuller Levis G, Quinn MR, Wright C et al. Taurine protects against oxidant-induced lung injury: possible mechanism(s) of action. Adv Exp Med Biol 1994; 359:31-9.
34. Tatsumi T, Fliss H. Hypochlorous acid and chloramines increase endothelial permeability: possible involvement of cellular zinc. Am J Physiol 1994; 267: H1597-607.
35. Park E, Schuller Levis G, Quinn MR. Taurine chloramine inhibits production of nitric oxide and TNF-a in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol 1995; 154: 4778-84.
36. Quinn MR, Park E, Schuller Levis G. Taurine chloramine inhibits prostaglandin E2 production in activated RAW 264.7 cells by post-transcriptional effects on inducible cyclooxygenase expression. Immunol Lett 1996; 50: 185-8.
37. Park E, Alberti J, Quinn MR et al. Taurine chloramine inhibits the production of superoxide anion, IL-6 and IL-8 in activated human polymorphonuclear leukocytes. Adv Exp Med Biol 1998; 442: 177-82.
38. Kontny E, Grabowska A, Kowalczewski J et al. Taurine chloramine inhibition of cell proliferation and cytokine production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 1999; 42: 2552-60.
39. Marcinkiewicz J, Nowak B, Grabowska A et al. Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidase-halide system. Immunology 1999; 98: 371-8.
40. Park E, Jia J, Quinn MR et al. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin Immunol 2002; 102: 179-84.
41. Wirleitner B, Neurauter G, Nagl M et al. Down-regulatory effect of N-chlorotaurine on tryptophan degradation and neopterin production in human PBMC. Immunol Lett 2004; 93: 143-9.
42. Marcinkiewicz J, Kurnyta M, Biedron R et al. Anti-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms. Adv Exp Med Biol 2006; 583: 481-92.
43. Kim C, Cha YN. Production of reactive oxygen and nitrogen species in phagocytes is regulated by taurine chloramine. Adv Exp Med Biol 2009; 643: 463-72.
44. Martinez-Losa M, Cortijo J, Piqueras L et al. Taurine chloramine inhibits functional responses of human eosinophils in vitro. Clin Exp Allergy 2009; 39: 537-46.
45. Barua M, Liu Y, Quinn MR. Taurine chloramine inhibits inducible nitric oxide synthase and TNF-a gene expression in activated alveolar macrophages: decreased NF-kB activation and IkB kinase activity. J Immunol 2001; 167: 2275-81.
46. Kanayama A, Inoue J, Sugita-Konishi Y et al. Oxidation of IkB-a at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kB activation. J Biol Chem 2002; 277: 24049-56.
47. Quinn MR, Barua M, Liu Y et al. Taurine chloramine inhibits production of inflammatory mediators and iNOS gene expression in alveolar macrophages; a tale of two pathways: part I, NF-kB signaling. Adv Exp Med Biol 2003; 526: 341-8.
48. Marcinkiewicz J, Walczewska M, Olszanecki R et al. Taurine haloamines and heme oxygenase-1 cooperate in the regulation of inflammation and attenuation of oxidative stress. Adv Exp Med Biol 2009; 643: 439-50.
49. Muz B, Kontny E, Marcinkiewicz J et al. Heme oxygenase-1 participates in the anti-inflammatory activity of taurine chloramine. Amino Acids 2008; 35: 397-402.
50. Emerson DK, McCormick ML, Schmidt JA et al. Taurine monochloramine activates a cell death pathway involving Bax and caspase-9. J Biol Chem 2005; 280: 3233-41.
51. Klamt F, Shacter E. Taurine chloramine, an oxidant derived from neutrophils, induces apoptosis in human B lymphoma cells through mitochondrial damage. J Biol Chem 2005; 280: 21346-52.
52. Kontny E, Rudnicka W, Chorazy-Massalska M et al. Taurine chloramine inhibits proliferation of rheumatoid arthritis synoviocytes by triggering a p53-dependent pathway. Inflamm Res 2006; 55: 446-55.
53. Vogt W, Hesse D. Oxidants generated by the myeloperoxidase-halide system activate the fifth component of human complement, C5. Immunobiol 1994; 192:1-9.
54. Vogt W. Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Immunobiol 1996; 195: 334-46.
55. Stief TW, Kurz J, Doss MO et al. Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood. Thromb Res 2000; 97: 473-80.
56. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 2005; 77: 598-625.
57. Soupart P. Free amino acids of blood and urine in the human. In: Holden JT, ed. Amino Acid Pools. Amsterdam: Elsevier, 1962; 220-62
58. Thomas EL, Grisham MB, Jefferson MM. Preparation and characterization of chloramines. Methods Enzymol 1986; 132: 569-85.
59. Peskin AV, Winterbourn CC. Kinetics of the reactions of hypochlorous acid and amino acid chloramines with thiols, methionine, and ascorbate. Free Radic Biol Med 2001; 30: 572-9.
60. Peskin AV, Midwinter RG, Harwood DT et al. Chlorine transfer between glycine, taurine, and histamine: reaction rates and impact on cellular reactivity. Free Radic Biol Med 2004; 37: 1622-30.
61. Morrison M, Schonbaum GR. Peroxidase-catalyzed halogenation. Annu Rev Biochem 1976; 45: 861-88.
62. Gottardi W, Arnitz R, Nagl M. N-chlorotaurine and ammonium chloride: an antiseptic preparation with strong bactericidal activity. Int J Pharm 2007; 335: 32-40.
63. Nagl M, Gottardi W. Rapid killing of Mycobacterium terrae by N-chlorotaurine in presence of ammonium is caused by the reaction product monochloramine. J Pharm Pharmacol 1998; 50: 1317-20.
64. Nagl M, Pfausler B, Schmutzhard E et al. Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa. Zent bl Bakteriol 1998; 288: 217-23.
65. Cunningham C, Tipton KF, Dixon HB. Conversion of taurine into N-chlorotaurine (taurine chloramine) and sulphoacetaldehyde in response to oxidative stress. Biochem J 1998; 330: 939-45.
66. Gottardi W, Hagleitner M, Nagl M. N,N-dichlorotaurine: chemical and bactericidal properties. Arch Pharm Pharm Med Chem 2005; 338: 473-83.
67. Nagl M, Hengster P, Semenitz E et al. The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J Antimicrob Chemother 1999; 43: 805-9.
68. Fürnkranz U, Nagl M, Gottardi W et al. N-chlorotaurine shows high in vitro activity against promastigotes and amastigotes of Leishmania species. J Med Microbiol 2009; 58: 1298-302.
69. Reeves EP, Nagl M, O'Keeffe J et al. Effect of N-chlorotaurine on Aspergillus, with particular reference to destruction of secreted gliotoxin. J Med Microbiol 2006; 55: 913-8.
70. Arnitz R, Nagl M, Gottardi W. Microbicidal activity of monochloramine and chloramine T compared. J Hosp Infect 2009; 73: 164-70.
71. Brodtmann NV, Russo PJ. The use of chloramine for reduction of trihalomethans and disinfection of drinking water. AWWA 1979; 71: 40-2.
72. Gottardi W, Nagl M. Chlorine covers on living bacteria: the initial step in antimicrobial action of active chlorine compounds. J Antimicrob Chemother 2005; 55: 475-82.
73. Marcinkiewicz J, Czajkowska B, Grabowska A et al. Differential effects of chlorination of bacteria on their capacity to generate NO, TNF-α and IL-6 in macrophages. Immunology 1994; 83: 611-6.
74. Gottardi W, Karl A. Chlorine covers on skin surfaces. I. Determination of the cover strength by the DPD-cuvette-method. Zent bl Hyg Umweltmed 1990; 190: 511-22.
75. Gottardi W, Karl A. Chlorine covers on skin surfaces. II. Parameters influencing the cover strength. Zent bl Hyg Umweltmed 1991; 191: 478-93.
76. Fuursted K, Hjort A, Knudsen L. Evaluation of bactericidal activity and lag of regrowth (postantibiotic effect) of five antiseptics on nine bacterial pathogens. J Antimicrob Chemother 1997; 40: 221-6.
77. Kaminski JJ, Huycke MM, Selk SH et al. N-halo derivatives V: comparative antimicrobial activity of soft N-chloramine systems. J Pharm Sci 1976; 65: 1737-42.
78. Arnitz R, Sarg B, Ott HW et al. Protein sites of attack of N-chlorotaurine in Escherichia coli. Proteomics 2006; 6: 865-9.
79. Koyama I, Nakamori K, Nagahama T et al. The reactivity of taurine with hypochlorous acid and its application for eye drops. Adv Exp Med Biol 1996; 403: 9-18.
80. Nagl M, Miller B, Daxecker F et al. Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye-a phase I clinical study. J Ocular Pharmacol Ther 1998; 14: 283-90.
81. Nagl M, Teuchner B, Pöttinger E et al. Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis-a phase II pilot study. Ophthalmologica 2000; 214: 111-4.
82. Teuchner B, Nagl M, Schidlbauer A et al. Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis - a double-blind randomized phase 2 clinical trial. J Ocular Pharmacol Ther 2005; 21: 157-65.
83. Teuchner B, Schmid E, Ulmer H et al. Tolerability of N-chlorotaurine plus ammonium chloride in the rabbit and human eye-a phase 1 clinical study. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1723-30.
84. Neher A, Nagl M, Schrott-Fischer A et al. N-chlorotaurine, a novel endogenous antimicrobial agent: tolerability tested in a mouse model. Arch Otolaryngol Head Neck Surg 2001; 127: 530-3.
85. Neher A, Nagl M, Prieskorn D et al. Tolerability of N-chlorotaurine in the guinea pig middle ear-a pilot study using an improved application system. Ann Otol Rhinol Laryngol 2004; 113: 76-81.
86. Neher A, Nagl M, Appenroth E et al. Acute otitis externa: efficacy and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent. Laryngoscope 2004; 114: 850-4.
87. Hofer E, Neher A, Gunkel AR et al. In vitro study on the influence of N-chlorotaurine on the ciliary beat frequency of nasal mucosa. Am J Rhinol 2003; 17: 149-52.
88. Neher A, Fischer H, Appenroth E et al. Tolerability of N-chlorotaurine in chronic rhinosinusitis applied via YAMIK catheter. Auris Nasus Larynx 2005; 32: 359-64.
89. Gstöttner M, Nagl M, Pototschnig C et al. Refractory rhinosinusitis complicating immunosuppression: application of N-chlorotaurine, a novel endogenous antiseptic agent. ORL J Otorhinolaryngol Relat Spec 2003; 65: 303-5.
90. Nagl M, Nguyen VA, Gottardi W et al. Tolerability and efficacy of N-chlorotaurine compared to chloramine T for treatment of chronic leg ulcers with purulent coating. Br J Dermatol 2003; 149: 590-7.
91. Mainnemare A, Megarbane B, Soueidan A et al. Hypochlorous acid and taurine-N-monochloramine in periodontal diseases. J Dent Res 2004; 83: 823-31.
92. Lorenz K, Mayer D, Bruhn G et al. Effect of N-chlorotaurine mouth rinses on plaque regrowth and plaque vitality. Clin Oral Investig 2009; 13: 9-14.
93. Huber J, Winter P, Gottardi W et al. Tolerability of N-chlorotaurine in the bovine mammary gland. J Dairy Res 2008; 75: 248-56.
94. Kwasny-Krochin B, Bobek M, Kontny E et al. Effect of taurine chloramine, the product of activated neutrophils, on the development of collagen-induced arthritis in DBA 1/J mice. Amino Acids 2002; 23: 419-26.
95. Verdrengh M, Tarkowski A. Inhibition of septic arthritis by local administration of taurine chloramine, a product of activated neutrophils. J Rheumatol 2005; 32: 1513-7.
96. Malle E, Waeg G, Schreiber R et al. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem 2000; 267: 4495-503.
97. Gupta RC, Seki Y, Yosida J. Role of taurine in spinal cord injury. Curr Neurovasc Res 2006; 3: 225-35.
98. Tomoda C, Kitano H, Uruno T et al. Transcutaneous iodine absorption in adult patients with thyroid cancer disinfected with povidone-iodine at operation. Thyroid 2005; 15: 600-3.
99. Grisham MB, Jefferson MM, Thomas EL. Role of monochloramine in the oxidation of erythrocyte hemoglobin by stimulated neutrophils. J Biol Chem 1984; 259: 6757-65.
100. Thomas EL, Grisham MB, Jefferson MM. Cytotoxicity of chloramines. Methods Enzymol 1986; 132: 585-93.
101. Neher A, Gstöttner M, Nagl M et al. N-chlorotaurine-a new safe substance for postoperative ear care. Auris Nasus Larynx 2007; 34: 19-22.
102. Geiger R, Treml B, Pinna A et al. Tolerability of inhaled N-chlorotaurine in the pig model. BMC Pulmon Med 2009; 9: 33.
103. Low E, Nair S, Shiau T et al. N,N-dichloroaminosulfonic acids as novel topical antimicrobial agents. Bioorg Med Chem Lett 2009; 19: 196-8.
104. Shiau TP, Houchin A, Nair S et al. Stieglitz rearrangement of N,N-dichloro-b,b-disubstituted taurines under mild aqueous conditions. Bioorg Med Chem Lett 2009; 19: 1110-4.
105. Wang L, Khosrovi B, Najafi R. N-chloro-2,2-dimethyltaurines: a new class of remarkably stable N-chlorotaurines. Tetrahedron Letters 2008; 49: 2193-5.